| Expression pattern: |
UP |
| Associated gene: |
PTEN |
| Associated microRNA: |
- |
| Biological function: |
Suppresses NSCLC cell apoptosis (oncogenic role). |
| Molecular mechanism: |
hsa_circ_0077837 increases PTEN gene methylation, downregulating PTEN expression, thereby reducing apoptosis. |
| Biological pathway or process: |
apoptosis (inhibits); PI3K/AKT (other); other pathway/process (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Cohort Study; Survival Analysis; Nuclear-Cytoplasmic Fractionation; Transfection; MSP (Methylation-Specific PCR); Western Blot; Annexin V/PI Flow Cytometry |
| Clinical significance: |
High hsa_circ_0077837 levels in cancer tissues predict poor survival of NSCLC patients and are higher in advanced stages (III+IV) than early stages (I+II). |
| Description: |
hsa_circ_0077837 is upregulated in NSCLC tissues and is associated with worse patient survival. In HCC827 cells, hsa_circ_0077837 overexpression increases PTEN gene methylation and reduces PTEN expression, thereby suppressing apoptosis; PTEN overexpression counteracts this effect. |
| Confidence score: |
0.7328 |